The bactericidal defect of CGD PMNs has been partially corrected in previous studies relying on the co-phagocytosis of bacteria and of either glucose oxidase (GO)-coated latex particles or GO-containing liposomes. We investigated the effect of opsonization of bacteria with an IgG-GO conjugate upon the bactericidal activity of CGD PMNs and monocytes (MC). Antistaphylococcal rabbit IgG was prepared and conjugated to GO by diethylmalonimidation. The conjugate (final concentration of IgG: 2.0 mglml) was used to opsonize bacteria which were then ingested by PMNs or MCs of female CGD carriers. In control preparations IgG alone was used as opsonin. After 120 minutes o: incubation with CGD PMNs, the number of surviving intracellular bacteria decreased from a mean of 42.3% (opsonin: IgG) to 17.7% (opsonin: IgG-GO conjugate). In MCs of CGD carriers the number of intracellular bacteria decreased by 45%. In PMN-free preparation the IgG-GO conjugate displayed negligible bactericidal activity. The bactericidal defect of CGD phagocytic cells can be successfully corrected by the intracellular introduction of an IgG-GO conjugate. Furthermore, such restoration of bactericidal activity may be enhanced by the close proximity between the bacteria and the hydrogen peroxide-generating opsonin. A 15 year old boy developed skin changes compatible with chronic graft versus host reaction (CGVHR) following bone marrow transplantation. His skin was thin, dry, inelastic, and telangiectatic. Biopsy revealed basal vacuolization, loss of rete pegs, atrophy of sweat glands, perivascular lymphocyte cuffing, and dense dermal collagenization. Because of the dermatologic similarity to PSS, we compared this patient to 38 PSS patients for evidence of systemic involvement. He had significant restrictive lung disease (VC and TLC 50% of predicted), cardiac conduction abnormalities (first degree heart block, right bundle branch block), and a pericardial effusion. Each of these abnormalities was found in 30-402 of the PSS group. Arteriolar intima1 proliferation was seen in the heart and kidneys of our patient at autopsy. This finding has been noted in approximately 25% of PSS patients. Our patient had Raynaud's phenomenon as di 95% of the PSS group. He had a striking polyclonal elevation in serum k G (4 gmsldl), an uncommon finding in PSS. 84% of the PS patients showed esophageal dysmotility, but our patient did not have this abnormality. The clinical and pathologic similarities between this patient and PSS patients suggest that CGVHR and PSS may have a common pathogenesis. The use of animal models of graft versus host reaction may lead to an understanding of mechanisms responsible for both disease processes. (P< 0.002). EPS generated more chemotaction Eor CC (P< 0.01) than-did EAS. In addition, s e r m IgE levels #ere determined on 6 of the asthmatic patients selected at rand m . The mean value of 733 units (range 473-1232) was about 2 1/2 times the normal value described for this age group. Defective CIS and RMs may be at least partly responsible for increased susceptibility to infection in asthmatics. Increased chemotaction by EPS may be due to unknown cytotactic factor (s). The nechanism of the PMN defects is unclear and may be related to in. zreased IgE levels and/or deactivation of receptors by pre-exis-,tin9 cytotactic factor (s).
PROGRESSIVE SYSTEMIC SCLEROSIS (PSS)-LIKE SYNDROME FOLLOWING BONE MARROW TRANSPLANTATION. m e 1 K. Roberts, Philip J. Clements, Daniel E. Furst Two children, 21 months and 11 years, with extensive intractable atopic dermatitis for life, recurrent pyogenic skin infections, hyperimmunoglobulinemia E, defective neutrophil chemotaxis and depressed cell-mediated immunity in vivo and in vitro were treated with transfer factor. Transfer Factor was prepared by the method of Lawrence from healthy donors with strong delayed type hypersensitivity to a battery of skin test antigens. Each patient received two courses of TF. A course was defined as 1x109 cells per week for 4 consecutive weeks. No clinical side-effects were noted. Following the first course of TF, significant clinical improvement was noted in both patients with disappearance of skin infections and pruritus. No new lesions have occurred 7 months after the completip of .therapy in the first patient and 2 months after the completion of therapy in the second patient despite the discontinuation of steroids and antibiotics. Immunologic evaluation showed no consistent improvement in vitro. However, post TF in both patients delayed type cutaneous reactivity converted to positive and serum IgE levels increased significantly. These findings suggest that TF may be beneficial in hyper-IgE syndrome although the significance of rising IgE remains to be determined. A 15 year old boy developed skin changes compatible with chronic graft versus host reaction (CGVHR) following bone marrow transplantation. His skin was thin, dry, inelastic, and telangiectatic. Biopsy revealed basal vacuolization, loss of rete pegs, atrophy of sweat glands, perivascular lymphocyte cuffing, and dense dermal collagenization. Because of the dermatologic similarity to PSS, we compared this patient to 38 PSS patients for evidence of systemic involvement. He had significant restrictive lung disease (VC and TLC 50% of predicted), cardiac conduction abnormalities (first degree heart block, right bundle branch block), and a pericardial effusion. Each of these abnormalities was found in 30-402 of the PSS group. Arteriolar intima1 proliferation was seen in the heart and kidneys of our patient at autopsy. This finding has been noted in approximately 25% of PSS patients. Our patient had Raynaud's phenomenon as di 95% of the PSS group. He had a striking polyclonal elevation in serum k G (4 gmsldl), an uncommon finding in PSS. 84% of the PS patients showed esophageal dysmotility, but our patient did not have this abnormality. The clinical and pathologic similarities between this patient and PSS patients suggest that CGVHR and PSS may have a common pathogenesis. The use of animal models of graft versus host reaction may lead to an understanding of mechanisms responsible for both disease processes. (P< 0.002) . EPS generated more chemotaction Eor CC (P< 0.01) than-did EAS. In addition, s e r m IgE levels #ere determined on 6 of the asthmatic patients selected at rand m . The mean value of 733 units (range 473-1232) was about 2 1/2 times the normal value described for this age group. Defective CIS and RMs may be at least partly responsible for increased susceptibility to infection in asthmatics. Increased chemotaction by EPS may be due to unknown cytotactic factor (s). The nechanism of the PMN defects is unclear and may be related to in. zreased IgE levels and/or deactivation of receptors by pre-exis-,tin9 cytotactic factor (s). The designation of K cells, effector cells of antibodydependent cell mediated cytotoxicity (ADCC), as T, B, or null cells has been controversial. Using reciprocally absorbed rabbit antisera to autologous T and B lymphoblast cell lines HSB and SB which detect human T and B lymphocyte antigens (HTLA and HBLA) (Blood 49:371, 1977; Clin. Immunol. Immunopath. 8:530, 1977) we now demonstrate that K cells are HTLA-positive/ HBLA-negative. Peripheral lymphocytes purified by nylon column filtration were incubated with anti-HTLA, anti-HBLA or normal rabbit serum5plus complement. Viable cells remaining were then tested in a Cr-release assay for cytotoxicity against antibody coated Chang liver cells. Treatment with anti-HTLA + C but not anti-HBLA + C abrogated ADCC. This was due to lysis of K cells rather than aptigen-antibody complex inhibition since no effect was seen with heat-inactivated complement. These findings support the concept that K cells belong to the T cell lineage.
ABNORMAL NEUTROPHIL (PMNS) CHEMOTAXIS

1 KILLER (K) CELLS RESPONSIBLE FOR ANTIBODY-DEPENDENT CELL HEDIATED CYTOTOXICITY EXPRESS H U L W T LYMPHO-
(Supported by NIH Grant CA17534. J.K is recipient of NIH RCDA cAooiaa). Department of Pediatrics. Boston. The effect of isoproterenol hydrochloride (I) on peripheral blood lymphocytes (PBL) rosette formation with sheep red blood cells (E) coated with C3 (EAC3) was studied. PBL from 25 allergi asthmatics, 25 normal subjects and 10 subjects with allergic rhinitis were separated over density gradients and incubated in RPMI medium and fetal calf serum (FCS) at 37OC overnight. From each subject 0.8 x 106 PBL were incubated with phosphate buffere saline or I for one hour at 3 7 O~, washed 3 times in Hanks' medium with FCS and rosetted with both E and EAC3 reagent. E rosette formation was similar for all groups and unaffected by I. Baseline EAC3 rosette number was similar for all groups (normals:12%; rhinitis:13%; asthma:13%). Incubation with I of PB from n o d 1 subjects and patients with rhinitis resulted in stat istically significant increases in the number of EAC3 rosette forming cells (normals-base:12%, I:19%, p<.001; rhinitis-base:13 I:20%, p<.001). Incubation with I of PBL from asthmatics resulte in no increase in the number of EAC3 rosette forming cells (asthma-base:13%, I:13%). Similar results were obtained with theophylline (Th) in 15 pairs of normals and asthmatics. Broncho dilator therapy did not affect the results in either normals (3) or asthmatics. The resistance of PBL from asthmatics to the enhancing effect of I and Th on EAC3 rosette formation may be used to study the biochemical defect in asthma and may provide an test for the detection of the latent asthmatic.
RESISTANCE OF BLOOD LYMPHOCYTES IN
